Sentiment Trading

Skye Bioscience Inc.’s stock price is currently at $2.87, with a market capitalization of $66.3 million, but faces challenges with a negative price-to-earnings ratio.

Skye Bioscience Inc. is navigating significant market volatility as it prepares to release its Q1 earnings report, which will be crucial in determining the company’s trajectory and ability to capitalize on opportunities in the healthcare sector.